EPISODE · Mar 3, 2026 · 1 MIN
Anifrolumab in the Real-World Management of Systemic Lupus Erythematosus
from TheBrief.Health · host TheBrief.Health
Real-world data show about one-quarter of lupus patients achieve six-month remission with anifrolumab, supporting earlier targeted therapy, steroid reduction, and evolving care pathways for systemic lupus erythematosus.
What this episode covers
Real-world data show about one-quarter of lupus patients achieve six-month remission with anifrolumab, supporting earlier targeted therapy, steroid reduction, and evolving care pathways for systemic lupus erythematosus.
NOW PLAYING
Anifrolumab in the Real-World Management of Systemic Lupus Erythematosus
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m